An Open-label Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis.
Phase of Trial: Phase I
Latest Information Update: 23 Dec 2015
Price : $35 *
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 16 Dec 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 26 Sep 2013 New trial record